4-Chloro-2-[4-(tetrahydro-pyran-4-yl)-piperidin-1-ylmethyl]-phenol, 250mg

5-Bromo-2-chlorothiazole, 95.0%, 5g

4-((Tetrahydrofuran-3-yl)oxy)aniline, 97%, 500mg

(S)-2,2-Diphenyl-2-(pyrrolidin-3-yl)acetonitrile hydrobromide, 97%, 5g

(S)-1-Benzyl 3-methyl piperazine-1,3-dicarboxylate hydrochloride, 95%, 1g

N,N-diethyl-3-[4-(2-methylpropyl)-5-sulfanylidene-4,5-dihydro-1H-1,2,4-triazol-3-yl]benzene-1-sulfonamide, 97%, 250mg

1-(2,6-Difluorophenyl)ethanamine hydrochloride, 97%, 5g

Z-DL-aspartic acid b-benzyl ester, 99.0%, 1g

Toluene, ROTISOLV® LSC, min. 99.5%, 1 l, glass packaging

Niobium tube 99+% 5.0 mm diameter, 0.3 mm wall thickness 100 mm

2,5-Bis(trifluoromethyl)benzoic acid, 98.0%, 25g

(R)-4-([1,1'-Biphenyl]-4-yl)-3-aminobutanoic acid hydrochloride, 95.0%, 250mg

2-amino-N-ethyl-5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophene-3-carboxamide, 95.0%, 5g